Specifically, L1CAM+ H-CTCs are significantly associated with lymph node metastasis, while L1CAM+ M-CTCs correlate with PR status, suggesting their potential involvement in tumor micrometastasis and hormone receptor-related pathways. This evidence concerns the gene L1CAM and metastatic malignant neoplasm in the lymph nodes.